Global HLA Typing Market is Projected to Reach USD 1.7 Billion by 2025, at a CAGR of 5.9% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "HLA Typing Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent), Application (Cancer Research, Infectious & Non Infectious Diseases, Transfusion Therapy), End User (Hospital, Academia and Research) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The HLA typing market is projected to grow at a CAGR of 5.9% during the forecast period.

Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research.

Reagents & consumables accounted for the largest market share in 2019.

Based on product and service, the HLA typing market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the HLA typing market in 2019. This can be attributed to the growing application horizons of molecular assay techniques in HLA typing, increasing patient emphasis on effective and early patient profiling during organ transplantation, the growing adoption of molecular diagnostic techniques in research studies, and the rising number of target procedures across major markets.

The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019.

On the basis of technology, the HLA typing market is segmented into molecular and non-molecular assay technologies. The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019. The growth of this segment is attributed to their benefits over non-molecular assays, such as low turnaround times, high procedural efficacy, multi-sample study capabilities, and real-time sample analysis.

The diagnostic applications segment accounted for the largest share of the HLA typing market in 2019.

Based on application, the HLA typing market is segmented into diagnostic and research applications. The diagnostic applications segment dominates the HLA typing market. This is attributed to technological advancements in molecular assay techniques, the increasing adoption of molecular assay procedures for pathogen encounter detection and histocompatibility cross-matching, and the growing incidence of chronic and infectious diseases.

The commercial service providers segment accounted for the largest share of the HLA typing market in 2019.

The HLA typing market, by end user, is segmented into commercial service providers, hospitals & surgical centers, and research laboratories & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the HLA typing market due to the ongoing rapid modernization and adoption of automation in HLA typing, growing outsourcing of R&D activities to said providers, and the increasing consolidation of diagnostic laboratories.

North America accounted for the largest share of the global HLA typing market in 2019.

The HLA typing market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global HLA typing market in 2019. This is majorly attributed to the high adoption of advanced diagnostic technologies, increasing prevalence of target diseases in the US and Canada, and technological advancements. The rising geriatric population and growing funding and support for research are other major factors driving the growth of this regional segment.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Key Topics Covered:

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.4 Currency Used for the Study

1.5 Major Market Stakeholders

2 Research Methodology

2.1 Research Data

2.2 Market Estimation Methodology

2.3 Data Triangulation

2.4 Research Assumptions

2.5 Research Limitations

3 Executive Summary

4 Premium Insights

4.1 HLA Typing Market: Market Overview

4.2 Global Market Breakdown, By Product & Service

4.3 Market, By Technology

4.4 Market, By Application

4.5 Market, By End User

4.6 Geographic Snapshot of the HLA Typing Market

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

6 HLA Typing Market, By Product & Service

6.1 Introduction

6.2 Reagents & Consumables

6.3 Instruments

6.4 Software & Services

7 HLA Typing Market, By Technology

7.1 Introduction

7.2 Molecular Assay Technologies

7.3 Non-Molecular Assay Technologies

8 HLA Typing Market, By Application

8.1 Introduction

8.2 Diagnostic Applications

8.3 Research Applications

9 HLA Typing Market, By End User

9.1 Introduction

9.2 Commercial Service Providers

9.3 Hospitals & Transplant Centers

9.4 Research Laboratories & Academic Institutes

10 HLA Typing Market, By Region

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 Latin America

10.6 Middle East and Africa

11 Competitive Landscape

11.1 Overview

11.2 Market Share Analysis

11.3 Competitive Scenario

11.4 Competitive Leadership Mapping

12 Company Profiles

12.1 Thermo Fisher Scientific

12.2 Qiagen

12.3 Illumina

12.4 F. Hoffman-La Roche Limited

12.5 Bio-Rad Laboratories

12.6 Becton, Dickinson and Company

12.7 TBG Diagnostics

12.8 Fujirebio

12.9 Takara Bio

12.10 Caredx

12.11 Omixon

12.12 Immucor

12.13 Genome Diagnostics

12.14 Biofortuna

12.15 Creative Biolabs

12.16 Other Companies

12.16.1 Bag Healthcare

12.16.2 Histogenetics

12.16.3 Pacific Biosciences of California

12.16.4 BGI Genomics

12.16.5 Krishgen Biosystems

For more information about this report visit https://www.researchandmarkets.com/r/mdfmyi